Outcomes of temozolomide and capecitabine chemotherapy used in neuroendocrine and endocrine tumours: A real-world comparison of treatment evidence in Alberta, Canada, from 2011-2021.
Authors: Alda Aleksi, Malek Hannouf, Patrik Husi
Published: 2025-05-28
DOI:
10.1200/jco.2025.43.16_suppl.e23064
Source:
Full article
Abstract
e23064